Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ergocalciferol
Drug ID BADD_D00794
Description Ergocalciferol is an inactivated vitamin D analog.[A177526] It is synthesized by some plants in the presence of UVB light.[T577] The production of ergocalciferol was prompted by the identification of dietary deficiency, more specifically vitamin D, as the main causative factor for the development of rickets. Ergocalciferol was isolated for the first time from yeast in 1931 and its structure was elucidated in 1932.[T580] Ergocalciferol is considered the first vitamin D analog and is differentiated from [cholecalciferol] by the presence of a double bond between C22 and C23 and the presence of a methyl group at C24. These modifications reduce the affinity of ergocalciferol for the vitamin D binding protein resulting in faster clearance, limits its activation, and alters its catabolism.[A177637] The first approved product containing ergocalciferol under the FDA records was developed by US Pharm Holdings and was FDA approved in 1941.[L6058]
Indications and Usage For use in the management of hypocalcemia and its clinical manifestations in patients with hypoparathyroidism, as well as for the treatment of familial hypophosphatemia (vitamin D resistant rickets). This drug has also been used in the treatment of nutritional rickets or osteomalacia, vitamin D dependent rickets, rickets or osteomalacia secondary to long-term high dose anticonvulsant therapy, early renal osteodystrophy, osteoporosis (in conjunction with calcium), and hypophosphatemia associated with Fanconi syndrome (with treatment of acidosis).
Marketing Status Prescription; Discontinued
ATC Code A11CC01
DrugBank ID DB00153
KEGG ID D00187
MeSH ID D004872
PubChem ID 5280793
TTD Drug ID D06JPB
NDC Product Code 60760-152; 49452-2760; 71335-1449; 68071-1951; 30698-493; 43353-219; 69452-151; 70518-0177; 43353-238; 68071-2352; 71335-0278; 71610-552; 10888-0140; 11014-0052; 60687-500; 63629-2447; 63629-7942; 71335-1699; 71335-0062; 68788-7627; 68071-2295; 42291-266; 50090-4382; 68071-1864; 11014-0026; 62332-464; 23155-809; 64980-157; 51407-143; 63187-519; 70934-252; 70518-1878; 43063-711; 51364-0007; 10888-8131; 64380-737; 63187-064; 66499-0041; 71335-1275; 50268-297; 71610-240; 63629-8144
Synonyms Ergocalciferols | Calciferols | Vitamin D 2 | Vitamin D2 | D2, Vitamin | Ergocalciferol
Chemical Information
Molecular Formula C28H44O
CAS Registry Number 50-14-6
SMILES CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.0010.000305%
Abdominal pain07.01.05.0020.000711%
Abdominal pain upper07.01.05.0030.000457%
Abortion spontaneous18.01.04.0010.000305%Not Available
Abscess11.01.08.0010.000102%Not Available
Acidosis14.01.03.002--
Acne23.02.01.0010.000152%Not Available
Acute myocardial infarction24.04.04.001; 02.02.02.0010.000254%Not Available
Alanine aminotransferase decreased13.03.01.0020.000102%Not Available
Alanine aminotransferase increased13.03.01.003--
Alopecia23.02.02.001--
Amnesia19.20.01.001; 17.03.02.0010.000102%
Anaemia01.03.02.001--
Anal fistula07.11.05.0020.000102%
Anaphylactic reaction24.06.03.006; 10.01.07.0010.000152%
Angina pectoris24.04.04.002; 02.02.02.0020.000152%
Ankle fracture12.04.01.005; 15.08.03.0050.000102%
Ankylosing spondylitis10.04.04.004; 15.01.09.0010.000102%Not Available
Anxiety19.06.02.002--
Aphasia19.21.01.001; 17.02.03.0010.000102%
Areflexia17.02.01.0010.000027%Not Available
Arrhythmia02.03.02.0010.000406%Not Available
Arteriosclerosis coronary artery02.02.01.011; 24.04.04.0120.000027%Not Available
Arthralgia15.01.02.0010.000965%
Arthritis15.01.01.0010.000254%
Asthenia08.01.01.0010.000965%Not Available
Asthma22.03.01.002; 10.01.03.0100.000203%Not Available
Atrial fibrillation02.03.03.0020.000254%
Atrial septal defect03.07.02.002; 02.04.02.0090.000102%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 15 Pages